Publications by authors named "C Potey"

Continuous compensation for cerebral dopamine deficiency represents an ideal treatment for Parkinson's disease. Dopamine does not cross the digestive and blood-brain barriers and is rapidly oxidized. The new concept is the intracerebroventricular administration of anaerobic dopamine (A-dopamine) using an abdominal pump connected to a subcutaneous catheter implanted in the third ventricle, near the striatum.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined the long-term effects of chronic diazepam use combined with alcohol on memory in aging mice, focusing on their potential impact on cognitive function.
  • Mice were divided into four groups and underwent 16 weeks of treatment with differing combinations of ethanol and diazepam, followed by memory tests and brain chemistry assessments.
  • Results indicated that while combined use during treatment negatively affected memory performance, there were no lasting effects on memory or hippocampal chemistry after discontinuation, suggesting benefits of stopping these substances.
View Article and Find Full Text PDF
Article Synopsis
  • - The use of Complementary Alternative Medicine (CAM), such as mushroom powder supplements, is on the rise among cancer patients but can pose risks, including liver damage and drug interactions with chemotherapy.
  • - A case study of a 43-year-old woman with metastatic colorectal cancer revealed that her liver issues were linked to her self-medication with mushroom capsules containing ABM; chemotherapy was halted due to her elevated liver enzyme levels.
  • - After stopping the supplement, her liver function improved, emphasizing the need for more disclosure between patients and healthcare providers regarding CAM use and the importance of analyzing these products for safety in cancer treatment.
View Article and Find Full Text PDF

Background: Ondansetron is an antiemetic drug (AED) used to prevent and treat nausea and vomiting. The summary of product characteristics reports a rare risk of transient blindness primarily during IV injections, notably with the concomitant use of chemotherapeutic agents. We aimed to refine the characterization of ondansetron-induced blindness.

View Article and Find Full Text PDF